XML 26 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated statements of stockholders' (deficit) equity (FY) - USD ($)
$ in Thousands
Total
DWSI
Previously Reported
Revision of Prior Period, Adjustment
ELOC
PIPE
Non-redeemable convertible preferred stock
Non-redeemable convertible preferred stock
DWSI
Non-redeemable convertible preferred stock
Previously Reported
Non-redeemable convertible preferred stock
Revision of Prior Period, Adjustment
Common stock
Common stock
DWSI
Common stock
Previously Reported
Common stock
Revision of Prior Period, Adjustment
Common stock
ELOC
Common stock
PIPE
Additional paid-in capital
Additional paid-in capital
DWSI
Additional paid-in capital
Previously Reported
Additional paid-in capital
Revision of Prior Period, Adjustment
Additional paid-in capital
ELOC
Additional paid-in capital
PIPE
Accumulated deficit
Accumulated deficit
Previously Reported
Accumulated deficit
Revision of Prior Period, Adjustment
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Previously Reported
Accumulated other comprehensive loss
Revision of Prior Period, Adjustment
Preferred stock, balance (in shares) at Dec. 31, 2019 [1]             120,115,206   135,012,939 (14,897,733)                                    
Common stock, balance (in shares) at Dec. 31, 2019 [1]                     13,540,768   15,220,212 (1,679,444)                            
Balance at Dec. 31, 2019 $ (103,868)   $ (103,868) $ 0     $ 152,091   $ 152,091 $ 0 $ 0   $ 16,337 $ (16,337)     $ 38,121   $ 21,784 $ 16,337     $ (283,704) $ (283,704) $ 0 $ (10,376) $ (10,376) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exercise of stock options (in shares) [1]                     10,009 890                                
Exercise of stock options 4 $ 1                 $ 0           4 $ 1                    
Exercise of warrants (in shares) [1]             278,604                                          
Exercise of warrants 818           $ 818                                          
Stock-based compensation 269 2,720                             269 2,720                    
Share issuance costs (110) (432)         $ (110) $ (432)                                        
Stock exchanged on transaction (in shares) [1]             (120,393,810)       (13,550,777) 2,723,014                                
Stock exchanged on transaction (169,146) 8,457         $ (152,799)                   (16,347) 8,457                    
Old DWSI fair value of warrants issued for services   450                               450                    
Conversion of preferred stock (in shares) [1]               24,078,762                                        
Conversion of preferred stock   160,690           $ 47,336                   $ 113,354                    
Issuance of stock (in shares) [1]               48,004,778                                        
Issuance of stock   43,679           $ 43,679                                        
DWSI Class B Preferred Stock issued on D-Wave convertible debt transfer (in shares) [1]               50,480,793                                        
Old DWSI Class B Preferred Stock issued on D-Wave convertible debt transfer   $ 99,298           $ 99,298                                        
Foreign currency translation adjustment, net of tax (82)                                                 (82)    
Net loss (10,019)                                           (10,019)          
Preferred stock, balance (in shares) at Dec. 31, 2020 [1]             122,564,333                                          
Common stock, balance (in shares) at Dec. 31, 2020 [1]                     2,723,904                                  
Balance at Dec. 31, 2020 $ 32,729           $ 189,881       $ 0           147,029           (293,723)     (10,458)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exercise of stock options (in shares) 105,203                   93,595 [1]                                  
Exercise of stock options $ 82                               82                      
Stock-based compensation 1,739                               1,739                      
Foreign currency translation adjustment, net of tax 15                                                 15    
Net loss $ (31,545)                                           (31,545)          
Preferred stock, balance (in shares) at Dec. 31, 2021 122,564,333           122,564,333 [1],[2]   137,765,828 (15,201,495)                                    
Common stock, balance (in shares) at Dec. 31, 2021 2,817,498                   2,817,499 [1],[2]   3,166,949 (349,450)                            
Balance at Dec. 31, 2021 $ 3,020 [2]   3,020 0     $ 189,881 [2]   $ 189,881 $ 0 $ 0 [2]   $ 2,610 $ (2,610)     148,850 [2]   146,240 2,610     (325,268) [2] (325,268) 0 (10,443) [2] (10,443) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exercise of stock options (in shares)                     8,768                                  
Exercise of stock options 7                               7                      
Stock-based compensation 783                               783                      
Foreign currency translation adjustment, net of tax (70)                                                 (70)    
Net loss (11,657)                                           (11,657)          
Preferred stock, balance (in shares) at Mar. 31, 2022             122,564,333                                          
Common stock, balance (in shares) at Mar. 31, 2022                     2,826,267                                  
Balance at Mar. 31, 2022 $ (7,917)           $ 189,881       $ 0           149,640           (336,925)     (10,513)    
Preferred stock, balance (in shares) at Dec. 31, 2021 122,564,333           122,564,333 [1],[2]   137,765,828 (15,201,495)                                    
Common stock, balance (in shares) at Dec. 31, 2021 2,817,498                   2,817,499 [1],[2]   3,166,949 (349,450)                            
Balance at Dec. 31, 2021 $ 3,020 [2]   $ 3,020 $ 0     $ 189,881 [2]   $ 189,881 $ 0 $ 0 [2]   $ 2,610 $ (2,610)     148,850 [2]   $ 146,240 $ 2,610     (325,268) [2] $ (325,268) $ 0 (10,443) [2] $ (10,443) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exercise of stock options (in shares) 1,380,609                   1,228,268 [1]                                  
Exercise of stock options $ 1,077                               1,077                      
Exercise of warrants (in shares) [1]                     121,261                                  
Exercise of warrants 959                               959                      
Stock-based compensation 9,164                               9,164                      
Conversion of preferred stock (in shares) [1]             (122,564,333)       96,764,117                                  
Conversion of preferred stock 0           $ (189,881)       $ 10           189,871                      
Issuance of stock (in shares) [1]                             2,260,346 5,816,528                        
Issuance of stock         $ 7,596 $ 40,000                   $ 1         $ 7,596 $ 39,999            
Merger, net of redemptions and transaction costs (in shares) [1]                     4,327,512                                  
Merger, net of redemptions and transaction costs (Note 3) (16,242)                               (16,242)                      
Foreign currency translation adjustment, net of tax 41                                                 41    
Net loss $ (51,529)                                           (51,529)          
Preferred stock, balance (in shares) at Dec. 31, 2022 0           0 [1]                                          
Common stock, balance (in shares) at Dec. 31, 2022 113,335,530 [1]                   113,335,530                                  
Balance at Dec. 31, 2022 $ (5,914)           $ 0       $ 11           381,274           (376,797)     (10,402)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Issuance of stock (in shares)         127,180 5,816,528                                            
Common stock, balance (in shares) at Aug. 05, 2022 110,007,972                                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exercise of warrants (in shares) 121,261                                                      
Preferred stock, balance (in shares) at Dec. 31, 2022 0           0 [1]                                          
Common stock, balance (in shares) at Dec. 31, 2022 113,335,530 [1]                   113,335,530                                  
Balance at Dec. 31, 2022 $ (5,914)           $ 0       $ 11           381,274           (376,797)     (10,402)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                        
Exercise of stock options (in shares) 672,583                   598,368                                  
Exercise of stock options $ 546                               546                      
Stock-based compensation 6,755                               6,755                      
Issuance of stock (in shares)                     13,239,654                                  
Issuance of stock 15,683                   $ 1           15,682                      
Foreign currency translation adjustment, net of tax (19)                                                 (19)    
Net loss $ (24,608)                                           (24,608)          
Common stock, balance (in shares) at Mar. 31, 2023 127,173,552                   127,173,552                                  
Balance at Mar. 31, 2023 $ (7,313)                   $ 12           $ 404,501           $ (401,405)     $ (10,421)    
[1] The shares of the Company's non-redeemable convertible preferred stock and common stock, prior to the Merger have been retrospectively restated to reflect the Conversion Ratio of 0.889657 established in the Merger.
[2] Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Merger.